美国私人保险患者中高合并症银屑病的经济负担数据集

数据集获取（Figshare）

• 源站标题：The economic burden of psoriasis with high comorbidity among privately insured patients in the United States
• DOI：10.6084/m9.figshare.7435874.v1
• 发布日期：2018-12-07
• 文件数：2 个
• 文件总体积：759.28 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/The_economic_burden_of_psoriasis_with_high_comorbidity_among_privately_insured_patients_in_the_United_States/7435874

命令行下载

curl -L -o "ijme_a_1557201_sm3413.tif" "https://ndownloader.figshare.com/files/13764875"
curl -L -o "ijme_a_1557201_sm3412.docx" "https://ndownloader.figshare.com/files/13764878"

文件清单

• ijme_a_1557201_sm3413.tif（740.16 KB）
• ijme_a_1557201_sm3412.docx（19.12 KB）

文件总体积 759.28 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Objective: To evaluate the impact of comorbidities on healthcare resource use (HRU), and direct and indirect work-loss-related costs in psoriasis patients.
Methods: Adults with psoriasis (≥2 diagnoses, the first designated as the index date) and non-psoriasis controls (no psoriasis diagnoses, randomly generated index date) were identified in a US healthcare claims database of privately-insured patients (data between January 2010 and March 2017 were used). Psoriasis patients were stratified based on the number of psoriasis-related comorbidities (0, 1–2, or ≥3) developed during the 12 months post-index. All outcomes were evaluated during the follow-up period, spanning the index date until the end of continuous health plan eligibility or data cut-off. HRU and costs per-patient-per-year (PPPY) were compared in psoriasis and non-psoriasis patients with ≥12 months of follow-up.
Results: A total of 9,078 psoriasis (mean age = 44 years, 51% female) and 48,704 non-psoriasis (mean age = 41 years, 50% female) patients were selected. During the 12 months post-index, among psoriasis vs non-psoriasis patients, 71.0% vs 83.0% developed no psoriasis-related comorbidities, 26.3% vs 16.0% developed 1–2, and 2.6% vs 1.0% developed ≥3 psoriasis-related comorbidities. Compared to non-psoriasis patients, psoriasis patients had more HRU including outpatient visits (incidence rate ratios [IRRs] = 1.52, 2.03, and 2.66 for 0, 1–2, and ≥3 comorbidities, respectively [all p p p p Conclusions: HRU and cost burden of psoriasis are substantial, and increase with the development of psoriasis-related comorbidities.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.7435874.v1（source: https://tandf.figshare.com/articles/dataset/The_economic_burden_of_psoriasis_with_high_comorbidity_among_privately_insured_patients_in_the_United_States/7435874）。